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EvolutionThe developmental origins of health and disease (DOHaD) is a paradigm for understanding metabolic
diseases of modern humans. Vulnerability to disease is linked to perturbations in development during critical
time periods in fetal and neonatal life. These perturbations are caused by environmental signals, often gener-
ated or transduced by the mother. The regulation of mammalian development depends to a large extent on
maternal biochemical signals to her offspring. We argue that this adaptation is ancient, and originated with
the evolution of lactation. Lactation evolved earlier than live birth and before the extensive placental devel-
opment of modern eutherian mammals. Milk contains a host of signaling molecules including nutrients,
immunoglobulins, growth factors and metabolic hormones. As evidenced by marsupials, lactation originally
served to supply the biochemical factors for growth and development for what is essentially a fetus to a
weanling transitioning to independent existence. In placental mammals maternal signaling in earliest life is
accomplished through the maternal–placental–fetal connection, with more of development shifted to in
utero life. However, signiﬁcant development occurs postpartum, supported by milk. Mothers of all taxa pro-
vide biochemical signals to their offspring, but for non-mammalian mothers the time window is short. Devel-
oping mammals receive maternal biochemical signals over an extended period. These signals serve to guide
normal development, but also can vary in response to environmental conditions. The ancient adaptation of
lactation resulted in a lineage (mammals) in which maternal regulation of offspring development evolved
to a heightened degree, with the ability to modify development at multiple time points. Modern metabolic
diseases may arise due to a mismatch between maternal regulation and eventual circumstances of the
offspring, and due to a large proportion of mothers that exceed past evolutionary norms in body fat and
pregnancy weight gain such that maternal signals may no longer be within the adaptive range.
© 2013 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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The developmental origins of health and disease (DOHaD) is a fun-
damental paradigm for investigating and understanding the etiology of
many of the metabolic diseases of modern humans (Barker, 1998,
2004; Gluckman and Hanson, 2005, 2006). Brieﬂy, environmental
signals have the potential to alter the developmental pathways of a
young organism resulting in eventual adult physiology andmetabolism
that is strongly affected by those early life signals. Thus, the physiolog-
ical health of an adult is shaped to a great extent by the circumstances
of early life, from in utero through early childhood. Obesity, diabetes,
hypertension, cardiovascular disease, asthma, allergies, and other condi-
tions all have potential origins in early life, both pre and postpartum.
Often, the environmental signal that affects development originates
from the mother. Mammalian mothers are signaling biochemically to
their offspring from the moment of implantation until weaning. The
maternal response to environmental challenges modulates her signal-
ing to her offspring, which in turn modulates offspring development.
The evidence for in utero effects on adult physiology and disease risk
in mammals is substantial, from the early epidemiological work of
Forsdahl (1977) and Barker (1990, 1993), to a host of experimental
studies on laboratory animals. There is also a growing body of evidence
for environmental effects in early postnatal life on later disease risk,
both direct and due to maternal effects (e.g. Gluckman et al., 2007).
Milk is a complex biochemical ﬂuid with essential function for the
growth and development of mammalian young. Milk is the sole food
for all mammals for some length of time after birth, and thus must
provide the essential nutrients required for early growth and devel-
opment. However, milk provides much more than nutrients. It has
been long known that maternal immunoglobulins (e.g. secretory
IgA) are transferred via milk, priming the neonatal immune system
(Hanson andWinberg, 1972; Cruz et al., 1982; Hanson et al., 1985). Re-
cent evidence demonstrates that milk also contains physiological con-
centrations of growth factors and metabolic hormones, such as
epidermal growth factor (EGF), leptin, and adiponectin (Savino et al.,
2011).Milk appears to have important developmental effects onneona-
tal intestinal health and development; for example, giving breast milk
to preterm infants reduces the incidence of necrotizing enterocolitis
(Sisk et al., 2007; Henderson et al., 2009; Arslanoglu et al., 2010).
Other hormones in milk (e.g. relaxin, leptin, adiponectin, and
insulin-like growth factors) may have developmental functions in the
neonate, affecting multiple organ systems from the gut to the brain.
The term lactocrinehas been proposed for thismaternal signaling to off-
spring viamilk (Bartol et al., 2008).
In essence, aspects of mammalian development, both pre and
postnatal, are strongly inﬂuenced by biochemical signals from the
mother. We suggest that the importance of maternal biochemical
signaling in guiding offspring development is an ancient adaptation
of mammals, dating back to the origin of lactation, and becoming
enhanced with the evolution of the placenta.1.1. Environmental effects on development
That the environment has signiﬁcant effects on growth and devel-
opment of organisms is a truism. At the least the environment must
be permissive of development. However, in many cases the environ-
ment guides development. An example is temperature dependent
sex determination, such as found in crocodilians and many other
reptiles. In the context of DOHaD in humans (and other mammals)environmental conditions result in variable phenotypic changes that
have later effects on physiology and metabolism, which alter the
risk of adult onset disease. These environmental signals can be direct,
but more often are considered to originate from or be transduced
through the mother (maternal effects).
The range of developmental outcomes arising from environmental
effects has different implications for the evolution of these changes by
selection. A developing organism that is energy or nutrient restricted
to an extent that still allows survival but results in a stunted individ-
ual may simply represent the best outcome possible given the envi-
ronmental constraint. The environment constrains more than guides
development in this instance. However, selection undoubtedly still
has acted on the developmental program such that under constraint
certain organ systems are spared at the expense of others. Some
deﬁcits of function will have greater adaptive consequences than
will others, and selection would act to favor deﬁcits with lesser ﬁtness
consequences over ones which reduce ﬁtness to a greater extent. For
example, in intrauterine growth restriction (IUGR) fetuses redistrib-
ute blood ﬂow such that the brain, heart and adrenals are less affected
than other organs. The greater head to abdominal circumference ob-
served in IUGR infants is largely explained by a greater impairment in
liver growth leading to a lower abdominal circumference (Nathanielsz,
2006). The organ sparing effect is relative; depending on the severity
of the IUGR brain and heart will also be affected, but to a lesser extent
than other organs.
However, the theory behind the development of adult disease due
to early life in humans suggests a subtler and more adaptive process.
If circumstances during early life are predictive of challenges to be
faced in later life than developmental changes in response to early
life circumstances could be adaptive for later life, and not merely
the best of a bad situation. In this scenario maternal circumstances
(e.g. plane of nutrition, disease history, social status) result in biochemical
signals to the developing offspring, both in utero through the maternal–
placental–fetal connection and after birth via milk, which are reliable
indicators of later life circumstances. The offspring's development is af-
fected to achieve an eventual physiology that is appropriate to its
expected later life condition.
This developmental programming is considered adaptive in the
short to medium term (relative to the reproductive life span) but
can result in later disease either because the resulting physiology is
not as robust as other outcomes (e.g. allows survival and reproduction
but results in frail or unhealthy physiology in late adult life), or
because the later life circumstances do not match the predicted and
the resulting mismatch in physiology and circumstances results in
poor health and increased metabolic disease.1.2. Maternal biochemical signaling to offspring
Mothers of all taxa signal biochemically to their offspring. Females
of oviparous taxa (e.g. birds and most reptiles) deposit substantial
resources into the egg, and from those resources the embryo will
develop until hatching. Obviously these maternal resources include
signaling molecules as well as the basic nutrients and other building
blocks of life. For example, maternally derived steroid hormones are
deposited into the egg, and the amounts of these hormones can
vary, presumably due to maternal circumstances. Experimental ma-
nipulations of steroid levels in eggs (by injecting into the egg) have
demonstrated that developmental characteristics of the offspring
can be affected. For example, bird egg androgen levels are associated
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ity, immune function, and begging behavior after hatching (Eising
et al., 2001, 2003; Navara et al., 2005; Schwabl, 1996). One difference
between an oviparous species and taxa with live birth, such as most
mammals, is that the time period duringwhich thematernal biochemical
signals can be directed at the offspring is severely constrained in ovipa-
rous species. The female cannot later alter what she has put into the egg.
In a placental mammal, such as humans, maternal biochemical
signaling is a continuous process over an extended period of maternal
dependence. It starts at implantation via the maternal–placental–fetal
axis, and continues postpartum via milk. An extensive amount of de-
velopment of mammalian fetuses and neonates depends upon signals
that originate in the mother. These signals change over time, not only
in a programmed way that matches the changing developmental
circumstances as the offspring age and mature, but also as maternal
circumstances change. Mammalian mothers may be able to alter
their developmental signals depending on the maternal environment,
or in some cases may have no choice, as the signaling depends upon
maternal circumstances. Again, this is possible for an egg laying verte-
brate such as a bird as well, but the time frame for mammals is much
broader. For most bird species, the maternal circumstances at the
time the egg is produced essentially determine the biochemical com-
position of the egg, and hence the signals transmitted to the develop-
ing embryo. For placental mammals the maternal circumstances at
the time of ovulation may have very little to do with the eventual
path of development for those processes that can be inﬂuenced by
maternal signaling. There are certainly essential time periods during
which development of species characteristics can be modiﬁed, but
for any given trait these time periods may be at any point of gestation
or even after birth.
Thus, for a mammal, a perturbation of maternal circumstances at
any point during the extensive period of offspring dependence
could have later life consequences for the offspring. In an experimen-
tal example, rat pups injected with leptin shortly after birth have al-
tered expression of hepatic 11β-hydroxysteroid dehydrogenase type
2 (11β-HSD2). However, the direction of the change depends upon
maternal circumstances during gestation. Pups from well nourished
dams showed an increase in 11β-HSD2 expression while pups from
dams that were food restricted by 30% showed a decrease in expres-
sion (Gluckman et al., 2007). The physiological reaction to a manipu-
lation was dependent upon maternal circumstances, presumably due
to the altered transfer of resources and signals from food-restricted
dams to their fetuses.
We argue that the ancient adaptation of lactation was the origin of
the mammalian pattern of substantial maternal regulation of off-
spring development and that mammals derive from a lineage for
which maternal regulation of offspring development was enhanced
and more ﬂexible than other vertebrate taxa. In effect, maternal reg-
ulation of offspring development over an extended period of offspring
maternal dependence is a signiﬁcant adaptive feature of mammalian
biology that probably predates the existence of mammals.
2. Placenta
The chorio-allantoic placenta is a more recent adaptation of
mammals compared to lactation, originating perhaps as recently as
100–110 million years ago (Murphy et al., 2001). Although a relative
novice compared to milk, the evolution of a chorio-allantoic placenta
increased the extent and sophistication of maternal–fetal biochemical
signaling in mammals. The human placenta connects a mother and
her baby physically, metabolically and immunologically. Made from
fetal cells, it is the ﬁrst organ any mammal ever makes. The evolution
of a placenta has inﬂuenced multiple aspects of mammalian biology,
especially for biological regulation, from metabolism to the genome.
The placenta allows biochemical signaling to go from offspring to
mother, as well as the reverse. Mothers and babies are “speaking” toeach other at a fundamental biological level from the moment of
implantation.
The placenta is, fundamentally, a regulatory organ, producing a
wide array of hormones, growth factors, cytokines, immune function
molecules and so forth (Petraglia et al., 2005). These molecules act lo-
cally as well as at a distance to affect the mother, the fetus and the
placenta itself, in essence exchanging information among these com-
partments in order to coordinate the necessary physiological and
metabolic processes required to produce a viable neonate. The intra-
uterine environment has been shown to have a strong inﬂuence over
growth and development, and to have signiﬁcant effects on offspring
future health and wellbeing long after birth. The placenta coordinates
maternal physiology with fetal development, and even plays a role in
stimulating maternal changes that prime the female for caregiving
behaviors after birth (Numan et al., 2006). The placental connection
that evolved in the extant eutherian mammal lineage increased the
duration, amount and ﬂexibility of the maternal–fetal exchange.
Placental inﬂuence extended to the evolution of genetic mecha-
nisms as well. The existence of this intimate connection increased
the salience and selective pressures inherent in the inevitable to
and fro of maternal–fetal and maternal–paternal genetic cooperation
and conﬂict regarding ﬁtness imperatives. Male and female mammals
are fundamentally different in their reproductive biology, and this
difference has profound evolutionary implications. The placenta is a
primary arena where maternal and paternal genes interact, in both
cooperation and conﬂict. The placenta appears to have allowed or
even driven changes in aspects of placental mammal genetic regula-
tion so that they differ fundamentally from that of other vertebrates
such as birds or amphibians. For example, imprinted genes appear
to be a therian mammal adaptation within vertebrates, with many
imprinted genes in placental and marsupial mammal species, but
none so far found in reptiles or even in the monotremes (Renfree
et al., 2013). Imprinted genes are important to placental development
and function; and the placenta as a reproductive adaptationwas a selec-
tive pressure for the evolution of gene imprinting (Reik and Lewis,
2005). The placenta appears to have inﬂuenced our biology at all levels.
3. The continuity of maternal signaling pre and postpartum
Not surprisingly, maternal signaling pre and postpartum often
shows continuity. For example, EGF and TGF-β are found in amniotic
ﬂuid (Underwood et al., 2005), which is swallowed by the developing
fetus. Thus, in utero the developing gut is exposed to these (and other
molecules) of maternal origin which likely have regulatory and devel-
opmental function and are necessary for the appropriate develop-
ment of the gut. After birth the signaling continues, now via milk. It
is instructive to consider that milk was the original source of most po-
tential maternal signals in early mammals. In marsupials it remains
the prime source. Thus, delivery of maternal signals to offspring orally
is an ancient adaptation in mammals. After the evolution of the
chorio-allantoic placenta, with the fetus enclosed within the amniotic
sac for a much longer period of development, fetal swallowing of am-
niotic ﬂuid allowed this signaling to continue. The adaptation of lacta-
tion may have served as a preadaptation to signaling via amniotic
ﬂuid.
4. Lactation
Lactation probably arose more than 250 million years ago in a
synapsid lineage from which mammals are the sole surviving descen-
dants. The original function of lactation is uncertain, though sugges-
tions generally revolve around a protective effect on eggs, either to
reduce desiccation and/or protect against microbial/fungal diseases
(Oftedal, 2002, 2012). The molecular evidence from milk proteins in-
dicate that some form of complex lactation was in existence a quarter
of a billion years ago. For example, α-lactalbumin, which functions to
Table 1
A partial list of signaling molecules detected in milk, most of which have also been
detected in amniotic ﬂuid.
Detected in amniotic ﬂuid
Epidermal growth factor (EGF) Yes
Hepatic growth factor (HGF) Yes
Vascular endothelial growth factor (VEGF) Yes
Basic ﬁbroblast growth factor (b-FGF) Yes
Insulin-like growth factor-I (IGF-I)
Platelet-derived growth factor (PDGF)
Transforming growth factor-β1 (TGF-β1)
Transforming growth factor-β2 (TGF-β2) Yes
Interleukin 4 (IL-4)
Interleukin 5 (IL-5)
Interleukin 6 (IL-6) Yes
Interleukin 10 (IL-10) Yes
Interleukin 13 (IL-13)
Interferon-gamma (IFN-γ) Yes
Relaxin Yes
Leptin Yes
Ghrelin Yes
Adiponectin Yes
Insulin Yes
Cortisol Yes
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plication of the lysozyme c gene. The original duplication event may
have preceded the divergence of the synapsid and diapsid (ancestors
of reptiles and birds) lineages (Prager and Wilson, 1988; Oftedal,
2012). Casein proteins derive from duplications of genes that code
for secretory calcium-binding phosphoproteins (Oftedal, 2012).
These are unfolded proteins that are associated with mineralized tis-
sue, and are involved in processes such as mineralization of tooth
enamel. The casein proteins in milk provide not only amino acids to
the offspring, but also most of the calcium and phosphorus. All
three types of casein genes (α-, β-, and κ-caseins) are found in mono-
tremes, marsupials and placental mammals, which puts their origin
prior to 170 million years ago, roughly coincident with the loss of
vitellogenin genes in mammals (Brawand et al., 2008), which have
nutrient transport function in reptile and bird egg yolk similar to
that of the caseins in milk.
Lactation as a reproductive adaptation has fundamentally affected
mammalian biology. It began the strong asymmetry in reproductive
effort between female and male mammals, placing the main repro-
ductive burden on mothers. It allowed the reduction of maternal
resources deposited into the egg, which has culminated in the
extremely nutrient-poor eggs of placental mammals that implant
and develop a chorio-allantoic placenta which nourishes the fetus
by transferring nutrients and gases from maternal circulation to the
fetus. After birth this intimate transfer of maternal resources to her
offspring continues via milk. The resources transferred include more
than just nutrients. Both milk and the placenta also allow mammalian
mothers to signal biochemically to their offspring over an extended
period, guiding the development of their young. Milk needs to be
examined from the perspective of regulatory and developmental
biology; to look beyond its nutritional importance and begin to inves-
tigate milk as a regulatory mechanism.
In the ancestral mammalian lineage, milk was the earliest mecha-
nism through which mothers signaled biochemically to their offspring.
In themarsupials it is still the primarymechanism,with almost all of the
resources and regulatory signaling delivered to offspring viamilk from a
fetal stage through weaning. Functions performed by the placenta are
accomplished through milk in marsupials. In the placental mammals
the placenta now plays a major role, but milk remains important. The
neonatal and infant period is one of substantial growth and develop-
ment, especially in humans. For example, a human infant's brain will
more than double in size during the time when, in our evolutionary
past the infant would have been completely reliant on mother's milk
for nutrition. Milk certainly provides the nutritional building blocks
for this growth and development. But milk is providing much more
than nutrition. Modern research has found that milk may provide
much of the regulatory signaling that directs infant growth and devel-
opment as well.
For example, important aspects of uterine wall development occur
in the ﬁrst few days after birth in female piglets (gilts), and these
morphogenetic changes are estrogen receptor dependent and estro-
gen sensitive (Chen et al., 2010a). Gilts fed milk replacer from birth
differed from gilts that nursed by having no detectable expression
of estrogen receptor-α or vascular endothelial growth factor (VEGF)
in uterine tissue (Chen et al., 2011). Exogenous relaxin enhanced es-
trogen receptor-α gene expression in nursed gilts but had no effect
on formula fed gilts, though it enhanced VEGF expression in both. Bio-
active factors in colostrum (earliest milk) appear to be necessary for
normal gene expression in gilt uterine tissue (Bartol et al., 2008;
Chen et al., 2011). Thus, the epigenetic programming of female piglet
uterine tissue development is regulated by maternal signals via milk.
4.1. Immune function molecules in milk
The ﬁrst evidence of maternal effects on offspring via milk
was the existence of maternal immunoglobulins in milk and theirimmunoprotective effect on her offspring (Fitzsimmons et al., 1994). In
humans and other species with hemochorial placentas immunoglobu-
lins also are transferred across the placenta during gestation. For humans
this is primarily IgG, with secretory IgA (sIgA) being transferred viamilk.
Other placental types (epithelialchorial and endothelialchorial pla-
centas) apparently cannot pass immunoglobulins. In species with those
placenta types (e.g. horses, dogs, prosimian primates) little or no mater-
nal immunoglobulin is transferred during gestation, and milk provides
the only avenue for transmission of maternal immunity to offspring; in
the milks of these species there are signiﬁcant concentrations of IgG as
well as sIgA (Van de Perre, 2003). Regardless, mothers are the source
of infant immunity to a variety of diseases.
Importantly, breast milk transfers not only passive immunity from
mother to offspring, but also contains proteins that direct the devel-
opment of the infant's immune system (Petherick, 2010). Human
breast milk contains immunomodulatory molecules, cytokines, and
hormones that coordinate the development of gut-associated lym-
phoid tissue and the development of the gut's barrier function and
innate defenses. The gut is an important immune organ. The skin,
lungs and gut are the organs that are constantly exposed to the exter-
nal environment, and thus are necessarily ﬁrst lines of defense.
Of course not all things transmitted to an infant viamilk are good.
Some pathogens can also be transmitted. Two recent case studies
concluded likely transmission of yellow fever live virus frommaternal
vaccination to her infant, probably via breast milk (Centers for
Disease Control, Prevention, 2010; Kuhn et al., 2011). West Nile
virus also appears able to be passed through breast milk (Centers for
Disease Control, Prevention, 2002), though the incidence of such occur-
rences is rare (Hinckley et al., 2007). Ofmost importance to public health
considerations, about 10% of maternal–child transmission of the HIV
virus occurs via breast milk (Dunn et al., 1992; Nduati et al., 2000). This
leads to a public health dilemma in the developing world, where
breastfeeding is an important factor protecting against diarrhea and
other diseases.
The efﬁciency of HIV viral transfer via breast milk is low. Without
antiviral drugs about 10–15% of breastfed infants will contract HIV
(Dunn et al., 1992; Coutsoudis et al., 2004). However, infants who
are exclusively breastfed are at lower risk of acquiring HIV than are
infants who are fed a mix of formula and breast milk or breast milk
and supplemental foods (Coovadia et al., 2007). There appear to be
factors in milk that inhibit HIV transfer. For example, HIV-infected
women with above average amounts of oligosaccharides in their
milk were less likely to transmit the virus, especially if the
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With highly active antiretroviral therapy (HAART) less than 3% of
breastfed infants will contract HIV. In a study of 102 HIV-infected
mothers undergoing HAART in Uganda, no infants were diagnosed
as HIV positive and the risk of infant death was six-fold higher
among infants breastfed for less than 6 months (Homsy et al.,
2010). In developing countries breastfeeding in conjunction with
HAART may be preferable to formula feeding despite the non-zero
risk of HIV transmission.4.2. Growth factors and metabolic hormones in milk
Breast milk contains a wide array of bioactive molecules (Table 1)
that likely play a role in shaping growth and metabolism in the
neonate (Savino et al., 2010). These include growth factors (e.g. the
insulin-like growth factors (IGFs), epidermal growth factor (EGF)
and transforming growth factor β (TGF-β)) and metabolic hormones
(e.g. ghrelin, leptin and adiponectin) that directly impact infant phys-
iology, particularly the developing gastrointestinal tract (Rautava and
Walker, 2009). A broad spectrum of evidence suggests that these sig-
naling molecules have important effects on growth and development
of neonates. Studies using in vitro and animal model approaches show
that milk bioactive factors such as IGF-I, TGF-ß, EGF, leptin, ghrelin,
and adiponectin are involved in epithelial proliferation, gut differen-
tiation, and suppression of gut inﬂammation, and shape growth andFig. 1. Body mass at 90 days for rat pups born to either a lean genotype dam (L) or an
obese phenotype dam (O) and cross fostered to either a lean or obese genotype dam.
L–L = lean–lean; O–L = lean–obese; O–O = obese–obese; L–O = lean–obese. Pup
phenotype matched the nursing dam genotype, although O–Omales were signiﬁcantly
larger than O–L males.
Data from Schroeder et al., 2010.metabolism in the neonate (Wagner, 2002). Feeding preterm infants
with human breastmilk reduces their risk of developing necrotizing en-
terocolitis, amajor source ofmorbidity in pretermbabies (Sullivan et al.,
2010). The speciﬁc signaling molecules in breast milk that act on the
infant's intestinal tract are not known, although EGF and TGF-β-2 are
logical candidates. Both of these growth factors have signiﬁcant effects
on intestinal epithelial cell proliferation and maturation (Coursodon
and Dvorak, 2012). Many other metabolic hormones found in milk
(e.g. leptin, adiponectin) have been suggested to play a role in the devel-
opment of infant metabolism, and to be potential risk factors for early
onset of obesity and type-2 diabetes (Savino et al., 2009, 2011).
Evidence from in vivo studies of premature infants, who experi-
ence enhanced gut maturation upon ingesting mother's milk which
contains higher levels of trophic factors further supports the critical
role of these bioactives in mediating neonatal and infant gut develop-
ment. The immature neonatal gut is poor at restricting the passage of
intact proteins into circulation, a factor suspected to be a major cause
of asthma and various food allergies. Breast milk is protective against
these risks (van Odijk et al., 2003; Scholtens et al., 2009). Breast milk
also may be protective against childhood obesity (Savino et al., 2009)
and may play an important role in the development of glucose regu-
latory physiology probably via milk-borne hormones such as leptin,
ghrelin and adiponectin (Savino et al., 2011).
Recent evidence suggests that mothers may pass on their meta-
bolic history to their infants. Maternal obesity predisposes offspring
to obesity and metabolic dysfunction in rodent models. Cross foster-
ing mouse pups from lean dams to obese dams during lactation
results in those pups becoming vulnerable to obesity and metabolic
disease (Gorski et al., 2006; Oben et al., 2010). Cross fostering
mouse pups that are predisposed to obesity onto lean dams lowers
the extent of obesity in the pups (Reifsnyder et al., 2000) and
improves insulin sensitivity (Gorski et al., 2006). Obesity-prone and
obesity-resistant rat pups displayed a phenotype consistent with
the foster (nursing) dam's genotype prior to weaning rather than to
their own genotype (Fig. 1), although after weaning their food intake
and weight gain reﬂected their own genotype (Schroeder et al., 2010).
There was an effect of sex, as male obesity-prone pups fostered to
obesity-resistant dams, although still becoming obese post-weaning,
had signiﬁcantly lower body weight and fat mass than obesity-prone
male pups nursed by obesity prone dams (Fig. 1; Schroeder et al.,
2010). Important aspects of early postnatal development appear to be
regulated to a signiﬁcant extent viamilk, though what bioactive factors
are most important are not yet known.
Human studies to date have shown limited evidence for milk
bioactive factors affecting growth and adiposity. Over the ﬁrst six
months of lactation milk adiponectin concentration was shown to
be negatively associated with weight-for-length and weight-for-age,
but not with length-for-age, implying lower adiposity in infants
drinking breast milk with high adiponectin (Woo et al., 2009). How-
ever, those infants experienced catch-up growth in the second year of
life, with an increase in adiposity (Woo et al., 2012). Higher concen-
tration of IL-6 in breast milk was associated with lower weight gain
and fat mass in infants (Fields and Demarath, 2012). Small for gesta-
tional age (SGA) infants who are breast fed gain less fat mass than
formula fed SGA infants and maintain a healthier metabolic proﬁle
in terms of circulating IGF-1 and high-molecular-weight adiponectin
(de Zegher et al., 2013). Previous studies using enriched formula
have shown that SGA infants that have greater catch-up growth
have higher fat mass (Singhal et al., 2010) and higher blood pressure
at 6 to 8 years of age (Singhal et al., 2007). The increased risk of
cardiovascular disease in later life for SGA infants may in part be
due to well-intentioned but possibly biologically unsound efforts to
enhance weight gain. Whether the slower growth and better meta-
bolic proﬁles of breast fed SGA infants is due solely to nutritional
factors or whether signaling molecules in breast milk contribute is
unknown.
Table 2
The 20 most abundant miRNAs detected in either breast milk or am-
niotic ﬂuid in order of abundance. miRNAs in bold are among the 20
most abundant for both breast milk and amniotic ﬂuid; miRNAs in
brackets were only found in either breast milk or amniotic ﬂuid,
and not in plasma, tears, urine, seminal ﬂuid, saliva, bronchial
lavage, cerebrospinal ﬂuid, pleural ﬂuid, or peritoneal ﬂuid.
Data from Weber et al., 2010.
Breast milk Amniotic ﬂuid
miRNA-335* miRNA-518e
miRNA-26a-2* miRNA-335*
miRNA-181d [miRNA-302c]
miRNA-509-5p miRNA-515-3p
miRNA-524-5p [miRNA-452]
miRNA-137 miRNA-892a
miRNA-26a-1* miRNA-671-5p
[miRNA-595] miRNA-515-5p
miRNA-580 miRNA-137
miRNA-130a [miRNA-593*]
miRNA-515-3p miRNA-590-3p
[miRNA-513c] miRNA-873
miRNA-671-5p miRNA-410
[miRNA-490-5p] miRNA-509-5p
miRNA-367 [miRNA-548d-5p]
miRNA-181b miRNA-223*
miRNA-598 miRNA-616*
miRNA-515-5p [miRNA-148b*]
[miRNA-578] miRNA-590-5p
miRNA-487b miRNA-302d
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pollution and the modern industrial world. Many of these compounds
have endocrine action or act as endocrine disruptors (e.g.PCBs, dioxins).
The concentrations and diversity of these contaminants varies mark-
edly between countries and within regions within a country. For
example, breast milk samples from Denmark and Finland could be
accurately distinguished by the relative concentrations of different
dioxins (Krysiak-Baltyn et al., 2009). These bioactive milk contami-
nants have the potential to affect development. For example, phthalates
are chemicals known to alter Leydig cell differentiation and function in
rodent models, and are now ubiquitous in the modern environment.
They are found in breast milk with wide variations in concentrations
among different regions. The concentration of different phthalates in
breast milk was associated with alterations in reproductive hormones
in three month old infants in Denmark and Finland, with higher
sex-hormone binding globulin, luteinizing hormone, and lower free
testosterone in infants of mothers with high breast-milk phthalate
concentrations (Main et al., 2006).
4.3. microRNA
Recent studies have detected signiﬁcant quantities of microRNAs
(miRNA), small regulatory RNA molecules, in human breast milk
(Kosaka et al., 2010; Zhou et al., 2012) and cow milk (Chen et al.,
2010b). Breast milk contained the highest concentration of total RNA
of 12 body ﬂuids tested, almost three times higher than seminal ﬂuid
which had the second highest concentration, and more than 80 times
the concentration found in amniotic ﬂuid (Weber et al., 2010). The
number ofmiRNAswith known function detected in breastmilk ranged
from 429 (Weber et al., 2010) to more than 600 (Zhou et al., 2012).
Among the twenty most common miRNAs detected in breast milk,
four were found only in breast milk and not in the other body ﬂuids
tested, and six were also found in amniotic ﬂuid (Table 2).
Many of the miRNAs found in milk have immune-related function,
regulating T-cells and inducing B-cell differentiation, and thus have
the potential to activate and potentiate immune function. Immune
cell-related miRNAs comprised the majority of miRNAs found in cow
milk (Chen et al., 2010b). Two-thirds of the well-characterized human
immune-related pre-miRNAs were detected in breast milk (Zhouet al., 2012). However, the existence of many human miRNAs in breast
milk that are not immune-related suggests that milk miRNAs may reg-
ulate physiological processes outside of the immune system as well.
These milk miRNAs appear resistant to degradation by acid and
RNase digestion, suggesting they could survive the acidic stomach
and digestive enzymes of the small intestine (Kosaka et al., 2010).
This resistance to degradation is likely due to the miRNAs being
contained within exosomes, tiny endosome-derived membrane vesi-
cles that are released by cells into the extracellular environment
(Zhou et al., 2012). Microvesicles (likely exosomes) containing
miRNA have also been found in cow milk (Hata et al., 2010). Breast
milk miRNAs likely survive intact into the small intestine, where
they can be taken up by lumen epithelium. They may represent
another regulatory mechanism allowing the maternal genome to
inﬂuence development of her offspring.
4.4. Epigenetics, imprinted genes and lactation
The mammary gland undergoes extensive remodeling during the
end of pregnancy in order to become a functioning lactating gland,
and then at the end of lactation during involution to return to the
non-lactating state. Not surprisingly, evidence is accumulating that
the dramatic changes in peptide production and secretion by the
mammary gland during lactation is accomplished at least in part
through epigenetic changes (reviewed in Rijnekls et al., 2010). There
is evidence of hypomethylation of DNA in epithelial cells from lactating
mammary glands at various lactation-related genes such as those for
casein proteins (Johnson et al., 1983; Thompson and Nakhasi, 1985)
and whey acidic protein (Dandekar et al., 1982). The promoter region
for the bovine αS1-casein gene is hypomethylated during lactation,
but becomes remythylated during mastitis (Vanselow et al., 2006) and
during involution (Singh et al., 2008). Prolactin appears to exert some
of its lactogenic effects by interacting with glucocorticoids to regulate
gene expression (Rosen et al., 1999), in part by creating a more open
chromatin structure (Rijnkels et al., 2010).
Lactational performance of dairy cows can be affected by early life
nutritional manipulations, with a program of initial energy restriction
followed by replenishment in young heifers resulting in approximately
10% greater milk yield as adults (Park, 2005). Whether that change is
passed on to daughters is uncertain, with studies giving contradictory
results (reviewed in Singh et al., 2012).
Genetic imprinting also appears important in the mammary gland.
In mouse mammary epithelial cells the maternal X chromosome is
non-randomly silenced (Jiao et al., 2012). In humans monoallelic
expression of Igf2 by mammary epithelium is the norm (Yun et al.,
1999). The insulin gene was monoallelically expressed in mammary
tissue of the marsupial, the tamar wallaby (Stringer et al., 2012).
The mammary gland appears to be a potential hot spot for imprinted
genes, along with the brain and placenta.
4.5. Gut biome
Breast milk is a major avenue and facilitator for infant gut microbe
colonization. Not only does breast milk contain microorganisms, but
some of the oligosaccharides in milk appear to act as prebiotics,
with certain commensal gut microbes (e.g. Biﬁdobacterium infantis)
able to metabolize certain human milk oligosaccharides while many
pathogenic strains cannot (Ward et al., 2006; Sela and Mills, 2010).
Thus breast milk both provides a source of microbes and a source of
energy for speciﬁc microbial strains.
The gut microbial populations of breastfed infants differ from that
of bottle fed infants (Bezirtzoglou et al., 2011), and generally reﬂect
their mother's gut biome. Breast milk contains staphylococci, strepto-
cocci, biﬁdobacteria and lactic acid bacteria, and the same strains that
are found in a mother's milk are usually found in her infant's feces
(Martín et al., 2012). Many of the bacteria found in breast milk are
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organisms (Martín et al., 2004). This suggests that breast milk may
be a vehicle by which mothers colonize their babies' guts with mater-
nal gut microbes.
The origin of what appear to be maternal gut microbes in breast
milk is somewhat controversial. The standard theory was that bacte-
ria in milk were the result of contamination frommaternal skin or the
infant's oral cavity. And both these surfaces likely do contribute some
microbes to the breast and into the milk. Recently, the existence of an
enteric–mammary transport system that encapsulates bacteria from
the maternal gut and transports it to the mammary gland has been
suggested (Martín et al., 2012; Fernández et al., 2013). Dendritic
cells have been shown to be able to penetrate the gut epithelium
and take up bacteria from the lumen (Rescigno et al., 2001). Intestinal
dendritic cells can retain small numbers of live bacteria for several
days (Macpherson and Uhr, 2004). Macrophages may also be able to
take up, retain and then disperse live bacteria. Transfer of live gut bac-
teria to mesenteric lymph nodes and to the mammary gland occurs
during late pregnancy and lactation in mice (Perez et al., 2007). The
feces of infants born by cesarean section to women given oral
lactobacilli during gestation contain that strain of lactobacilli, even
though they were not exposed to the vaginal environment (Schultz
et al., 2004). Milk is the likely colonizing source, implying that live
lactobacilli in the maternal gut can reach the mammary glands.
The gut biome contains at least two orders of magnitude more
expressed DNA than does the human host genome, and it produces
a large array of biologically active products that can affect other gut
residents, gut epithelium, and even be absorbed into circulation. The
gut biome has recently been shown to play a large role in physiolog-
ical processes. For example, malnutrition has been linked to differ-
ences in the gut biome in a study of twins in Malawi. There was
evidence that the gut biome differences not only potentially affected
digestive and absorptive efﬁciency, but were actually related to
changes in regulation of aspects of the Krebs cycle in these children
(Smith et al., 2013).
Thus, it appears thatmothers can inoculate their infantswithmater-
nal gutmicrobes viamilk,with potential physiological consequences for
the infants. An aberrant gut biome is associated with increased disease
risk in infants (Isolauri, 2012). Interestingly, obese women produce
milkwith a less diverse set ofmicrobes, andwomenwho gain excessive
weight produce milk with different microbes from those in milk of
women who had normal weight gain during pregnancy
(Cabrera-Rubio et al., 2012). Obesity in adults is associated with an al-
tered gut microbial population. Obese mothers may pass on their
obesogenic gut biome to their breast fed infants.
5. Adaptive consequences of maternal control of development
Maternal control of development presents advantages and chal-
lenges to both mother and offspring. Ceding control of certain develop-
mental processes to themother reduces fetal endogenous requirements
by taking more from the maternal system. This might even be required
in mammalian embryonic life, as the fetal organs and regulatory sys-
tems may not be mature enough and the resources initially transferred
into the egg are so minimal that endogenous regulation may not be
possible. Although it extends the time period during which mothers
transfer resources to offspring, it reduces the daily extent of the
resource transfer, spreading the cost over time. Most likely a strong
maternal inﬂuence on fetal and neonatal development is usually a
win–win for both mother and offspring; but it does provide grounds
for maternal–offspring conﬂict. For example, greater the maternal
control allows a withdrawal of resources due to maternal circum-
stances, in extreme cases aborting; adaptive for the mother, but not
for the fetus. Thus, maternal–offspring conﬂict has become potentially
heightened in mammals, especially as the fetus has acquired a greater
ability to inﬂuence its mother via placental signaling.The greatly extended time frame over which mammalian mothers
can inﬂuence offspring development increases the ﬂexibility of pheno-
type. The genotype–environment interaction is transduced through the
mother to a large extent; and changes in maternal circumstances can
potentially affect offspring development at many time points from
implantation through weaning. Unfortunately in the modern human
environment maternal circumstances may not be as predictive of the
infant's post-weaning nutritional plane as itwas in our past. In develop-
ing countries this can lead to a mismatch between an impoverished
maternal circumstances but a consistent higher-calorie intake by her
offspring. In developed countries,maternal circumstances have exceeded,
in terms of fatmass and plane of nutrition, the evolutionary norm. In the
past very few babies were born to mothers with body mass indices
above 30 kg/m2 orwhogainedmore than 40 lb during gestation. Gesta-
tional diabetes was very rare. The signals coming to infants from their
mothers may be well outside of the normative ranges under which
our species evolved. The infant's metabolism and physiology will still
adjust in response to those signals, but the adjustments may no longer
represent an adaptive response; or at least may not result in long-term
good health. The mammalian adaptation of extensive and long term
maternal inﬂuence on development that we hypothesize began with
the evolution of lactationmay underliemanymodern humanmetabolic
diseases. The modern human pathologies associated with DOHaD may
represent the failure of an adaptive response due to an inappropriate
environment.
6. Conclusions
1. The mammalian lineage has adapted a strategy of signiﬁcant ma-
ternal control of offspring development from embryo to weanling.
We hypothesize that the origin of that adaptation was the evolu-
tion of lactation.
2. Milk contains a host of bioactive substances (e.g. immuno, regula-
tory, and microbial) many of which likely survive the acid stomach
and enter the infant's small intestine. These substances can affect
intestinal epithelial cells, be absorbed into circulation, or, in the
case of microbes, affect the infant's gut biome. And all can affect
development and metabolism.
3. Milk continues oral biochemical signaling that in the fetus occurs
via swallowing amniotic ﬂuid. Milk is the more ancient adaptation
for oral maternal biochemical signaling to offspring, and preadapted
mammalian fetuses to receive signaling via amniotic ﬂuid.
4. The evolution of the chorio-allantoic placenta increased the com-
plexity of maternal–fetal signaling, and has enhanced the variation
in development and metabolism that arises from maternal signals.
5. We hypothesize that the developmental diseases that plague mod-
ern humans arise frommismatches between this evolved, adaptive
maternal regulation of development and the modern environment.
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